Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 75907-225

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 75907-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Azacitidine For Injection 100 mg/vial by Dr. Reddy's Laboratories Inc. The label indicates the product is for subcutaneous and intravenous use only, is a cytotoxic agent, lyophilized powder that must be diluted, and contains one single-dose vial. Storage instructions specify 20°C to 25°C (68°F to 77°F). Distributor is Dr. Reddy's Laboratories Inc., Princeton, NJ, made in India. The label includes NDC 75907-225-11 and barcode.*

FDA Label Image

Vial (Vial)

Label for Azacitidine Injection 100 mg/vial by Dr. Reddy's Laboratories Inc. The label indicates it is a lyophilized powder for injection, intended for subcutaneous and intravenous use. It specifies one single-dose vial, noting the drug is cytotoxic and must be diluted before use. Storage instructions and distributor information are also present on the label.*

FDA Label Image

Graph (Graph)

A Kaplan-Meier survival curve comparing the proportion surviving over time (months) from randomization for two groups, AZA and CCR. The chart shows survival probabilities up to 40 months, with AZA having a higher survival proportion throughout the period. The figure includes a log-rank p-value of 0.0001, hazard ratio, and number of deaths for each group, along with the number at risk over time for AZA and CCR.*

FDA Label Image

Structure (Structure)

Chemical structure of azacitidine showing its molecular composition with nitrogenous base and sugar moiety, consistent with the active ingredient azacitidine in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.